Home/Filings/4/0001209191-23-030202
4//SEC Filing

Lemaitre Dan 4

Accession 0001209191-23-030202

CIK 0001237831other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 4:31 PM ET

Size

20.4 KB

Accession

0001209191-23-030202

Insider Transaction Report

Form 4
Period: 2023-05-15
Lemaitre Dan
Director
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2023-05-15$23.95/sh+1,450$34,72812,250 total
  • Sale

    Class A Common Stock

    2023-05-15$56.98/sh43,450$2,475,97710,800 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2023-05-1514,0000 total
    Exercise: $25.52Exp: 2026-01-25Class A Common Stock (14,000 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2023-05-15$24.10/sh+10,500$253,05022,750 total
  • Exercise/Conversion

    Class A Common Stock

    2023-05-15$25.52/sh+14,000$357,28036,750 total
  • Exercise/Conversion

    Class A Common Stock

    2023-05-15$26.27/sh+17,500$459,72554,250 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2023-05-151,4500 total
    Exercise: $23.95Exp: 2024-01-23Class A Common Stock (1,450 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2023-05-1510,5000 total
    Exercise: $24.10Exp: 2025-01-20Class A Common Stock (10,500 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2023-05-1517,5000 total
    Exercise: $26.27Exp: 2027-01-30Class A Common Stock (17,500 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.77 to $57.215, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]These options were granted on January 23, 2014 and are fully vested.
  • [F3]These options were granted on January 20, 2015 and are fully vested.
  • [F4]These options were granted on January 25, 2016 and are fully vested.
  • [F5]These options were granted on January 30, 2017 and are fully vested.

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0001478479

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:31 PM ET
Size
20.4 KB